全球先兆子癇診斷市場研究報告 - 2023-2030 年行業分析、規模、份額、增長、趨勢和預測

全球對先兆子癇診斷市場的需求將從2022年的13.7332億美元增長到2030年的41.7769億美元，2023-2030年調查期間的複合年增長率為14.92%，預計將達到

先兆子癇是妊娠期高血壓綜合症的一種，據稱全球約有5%的孕婦受累，其中0.5%至1%會發展為重症。 妊娠20週後，新發的高血壓和蛋白尿是先兆子癇的診斷標準。

市場動態

全球先兆子癇診斷市場主要受先兆子癇發病率上升的推動。 由於對其檢測和治療的需求不斷增加，先兆子癇診斷市場預計將擴大。 隨著孕產婦和圍產期死亡率和發病率的上升，預計對孕婦早期檢測先兆子癇的需求將會增加。 此外，檢測先兆子癇生物標誌物的新測試的研發進展有望推動市場增長。 此外，醫療保健提供者對這種疾病的有效篩查工具的認識不斷提高，以及對孕婦先兆子癇相關症狀和體徵的了解不斷增加，這些都在迅速推動先兆子癇診斷市場的發展。預計

這份研究報告解釋了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外，這些工具還對全球先兆子癇診斷市場的每個部分進行了全面評估。 先兆子癇診斷行業的發展和趨勢為這項研究提供了一種整體方法。

市場細分

本部分提供有關國家/地區細分市場的詳細數據，以幫助戰略制定者確定各自產品和服務的目標受眾，並將他們與未來的商機聯繫起來。.

按測試類型

• 驗血
• 尿液分析

按產品類型

• 儀器
• 消耗品

由最終用戶

• 醫院
• 專科門診
• 診斷中心
• 其他

區域分析

本節對北美、歐洲、亞太地區、拉丁美洲、中東和非洲的先兆子癇診斷市場的當前和未來需求進行區域展望。 此外，該報告重點關注所有主要地區每個單獨應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 先兆子癇診斷市場的主要參與者是 F. Hoffmann-La Roche Ltd.、PerkinElmer Inc.、DRG INSTRUMENTS GMBH、Thermo Fisher Scientific Inc.、Diabetomics, Inc.、Metabolomics Diagnostics Ltd.、Sera Prognostics、Siemens Healthineers AG，□□例如Bayer AG。 本節全面介紹了競爭格局，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。

如果您有任何定制要求，請告訴我們。 我們的研究團隊可以根據您的需要提供定制報告。

內容

第一章前言

• 報告內容
  • 目的
  • 目標受眾
  • USP（獨特的銷售建議）及其提供的內容
• 調查範圍
• 調查方法
  • 市場調研流程
  • 市場研究方法

第 2 章執行摘要

• 市場亮點
• 全球市場概況

第 3 章先兆子癇診斷 - 行業分析

• 簡介 - 市場動態
• 市場驅動因素
• 市場製約因素
• 機會
• 行業趨勢
• 波特的五力分析
• 市場吸引力分析
  • 按測試類型
  • 按產品類型
  • 最終用戶
  • 按地區

第四章價值鏈分析

• 價值鏈分析
• 原材料分析
  • 原材料清單
  • 原材料製造商名單
  • 主要原材料價格走勢
• 潛在買家名單
• 營銷渠道
  • 直接營銷
  • 間接營銷
  • 市場發展趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章按測試類型分列的全球先兆子癇診斷市場分析

• 按測試類型匯總
• 過去和未來的數據
• 按測試類型分析
• 血液檢測市場：按地區
• 尿液分析市場：按地區

第 7 章按產品類型分列的全球先兆子癇診斷市場分析

• 摘要：按產品類型
• 過去和未來的數據
• 分析：按產品類型
• 儀器市場：按地區
• 消費市場：按地區

第 8 章先兆子癇診斷的全球市場分析：按最終用戶分類

• 最終用戶總結
• 過去和未來的數據
• 最終用戶分析
• 醫院市場：按地區
• 專科診所市場：按地區
• 診斷中心市場：按地區
• 其他市場：按地區

第 9 章先兆子癇診斷的全球市場分析：按地區

• 區域展望
• 簡介
• 北美
  • 摘要、實際數據、預測數據
  • 按北美細分
  • 北美：按國家/地區列出
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 摘要、實際數據、預測數據
  • 歐洲（按細分市場）
  • 歐洲：按國家/地區分類
  • 英國
  • 法國
  • 德國
  • 意大利
  • 俄羅斯
  • 其他歐洲
• 亞太地區
  • 摘要、實際數據、預測數據
  • 按亞太地區細分
  • 亞太地區：國家/地區信息
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳大利亞
  • 其他亞太地區
• 拉丁美洲
  • 摘要、實際數據、預測數據
  • 拉丁美洲細分市場
  • 拉丁美洲：按國家/地區列出
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲地區
• 中東和非洲
  • 摘要、實際數據、預測數據
  • 中東和非洲分部信息
  • 中東和非洲：按國家/地區列出
  • 沙特阿拉伯
  • 阿聯酋
  • 以色列
  • 南非
  • 其他中東和非洲地區

第十章子癇前期診斷企業競爭格局

• 先兆子癇診斷市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他擴展

第11章公司簡介

• 公司股票分析
• 市場集中度
• F. Hoffmann-La Roche Ltd.
  • 公司概況
  • 產品介紹
  • 近期趨勢
• PerkinElmer Inc.
  • 公司簡介
  • 產品介紹
  • 近期趨勢
• DRG Instruments GMBH
  • 公司簡介
  • 產品介紹
  • 近期趨勢
• Thermo Fisher Scientific Inc.
  • 公司簡介
  • 產品介紹
  • 近期趨勢
• Diabetomics, Inc.
  • 公司簡介
  • 產品介紹
  • 近期趨勢
• Metabolomic Diagnostics Ltd.
  • 公司簡介
  • 產品介紹
  • 近期趨勢
• Sera Prognostics
  • 公司簡介
  • 產品介紹
  • 近期趨勢
• Siemens Healthineers AG
  • 公司簡介
  • 產品介紹
  • 近期趨勢
• Bayer AG
  • 公司簡介
  • 產品介紹
  • 近期趨勢

注意：在公司簡介、財務細節、近期發展等方面，基於可用信息，私人控股公司可能不包括在內。

The global demand for Preeclampsia Diagnostics Market is presumed to reach the market size of nearly USD 4177.69 MN by 2030 from USD 1373.32 MN in 2022 with a CAGR of 14.92% under the study period 2023 - 2030.

Preeclampsia is a hypertension condition of pregnancy that affects roughly 5% of all pregnant women worldwide, with 0.5 percent to 1% developing severe cases. After 20 weeks of pregnancy, new development of high blood pressure and proteinuria are diagnostic criteria for preeclampsia.

Market Dynamics

The global preeclampsia Diagnostics market is primarily driven by rising preeclampsia incidences. The market for preeclampsia diagnostics is predicted to expand due to the constantly increasing need for its detection and treatment. The demand for early detection of preeclampsia among pregnant women is expected to rise as maternal and perinatal death, and morbidity rates rise. Furthermore, the growing research and development of new tests to detect biomarkers that indicate preeclampsia are likely to promote market growth. Moreover, rising healthcare provider awareness of effective screening tools for the illness, and growing knowledge of the signs and symptoms related to preeclampsia among expecting mothers, are expected to propel the preeclampsia diagnostics market forward at a quick pace.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of preeclampsia diagnostics. The growth and trends of preeclampsia diagnostics industry provide a holistic approach to this study.

Market Segmentation

This section of the preeclampsia diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

• Blood Tests
• Urine Analysis

By Product Type

• Instruments
• Consumables

By End-User

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Preeclampsia Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the preeclampsia diagnostics market include F. Hoffmann-La Roche Ltd., PerkinElmer Inc., DRG INSTRUMENTS GMBH, Thermo Fisher Scientific Inc., Diabetomics, Inc., Metabolomic Diagnostics Ltd., Sera Prognostics, Siemens Healthineers AG, Bayer AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PREECLAMPSIA DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 By Test Type
  • 3.7.2 By Product Type
  • 3.7.3 By End-user
  • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PREECLAMPSIA DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

• 6.1 Overview by Test Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Test Type
• 6.4 Blood Tests Market by Regions
• 6.5 Urine Analysis Market by Regions

7 . GLOBAL PREECLAMPSIA DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

• 7.1 Overview by Product Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Product Type
• 7.4 Instruments Market by Regions
• 7.5 Consumables Market by Regions

8 . GLOBAL PREECLAMPSIA DIAGNOSTICS MARKET ANALYSIS BY END-USER

• 8.1 Overview by End-user
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-user
• 8.4 Hospitals Market by Regions
• 8.5 Specialty Clinics Market by Regions
• 8.6 Diagnostic Centers Market by Regions
• 8.7 Others Market by Regions

9 . GLOBAL PREECLAMPSIA DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America
  • 9.3.1. Overview, Historic and Forecast Data
  • 9.3.2. North America By Segment
  • 9.3.3. North America By Country
  • 9.3.4. United State
  • 9.3.5. Canada
  • 9.3.6. Mexico
• 9.4. Europe
  • 9.4.1. Overview, Historic and Forecast Data
  • 9.4.2. Europe by Segment
  • 9.4.3. Europe by Country
  • 9.4.4. United Kingdom
  • 9.4.5. France
  • 9.4.6. Germany
  • 9.4.7. Italy
  • 9.4.8. Russia
  • 9.4.9. Rest Of Europe
• 9.5. Asia Pacific
  • 9.5.1. Overview, Historic and Forecast Data
  • 9.5.2. Asia Pacific by Segment
  • 9.5.3. Asia Pacific by Country
  • 9.5.4. China
  • 9.5.5. India
  • 9.5.6. Japan
  • 9.5.7. South Korea
  • 9.5.8. Australia
  • 9.5.9. Rest Of Asia Pacific
• 9.6. Latin America
  • 9.6.1. Overview, Historic and Forecast Data
  • 9.6.2. Latin America by Segment
  • 9.6.3. Latin America by Country
  • 9.6.4. Brazil
  • 9.6.5. Argentina
  • 9.6.6. Peru
  • 9.6.7. Chile
  • 9.6.8. Rest of Latin America
• 9.7. Middle East & Africa
  • 9.7.1. Overview, Historic and Forecast Data
  • 9.7.2. Middle East & Africa by Segment
  • 9.7.3. Middle East & Africa by Country
  • 9.7.4. Saudi Arabia
  • 9.7.5. UAE
  • 9.7.6. Israel
  • 9.7.7. South Africa
  • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE PREECLAMPSIA DIAGNOSTICS COMPANIES

• 10.1. Preeclampsia Diagnostics Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF PREECLAMPSIA DIAGNOSTICS INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. F. Hoffmann-La Roche Ltd.
  • 11.3.1. Company Overview
  • 11.3.2. Financials
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. PerkinElmer Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financials
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. DRG Instruments GMBH
  • 11.5.1. Company Overview
  • 11.5.2. Financials
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Thermo Fisher Scientific Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financials
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Diabetomics, Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financials
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Metabolomic Diagnostics Ltd.
  • 11.8.1. Company Overview
  • 11.8.2. Financials
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Sera Prognostics
  • 11.9.1. Company Overview
  • 11.9.2. Financials
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Siemens Healthineers AG
  • 11.10.1. Company Overview
  • 11.10.2. Financials
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Bayer AG
  • 11.11.1. Company Overview
  • 11.11.2. Financials
  • 11.11.3. Products
  • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Test Type (USD MN)
• Blood Tests Market by Geography (USD MN)
• Urine Analysis Market by Geography (USD MN)
• Analysis Market by Product Type (USD MN)
• Instruments Market by Geography (USD MN)
• Consumables Market by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospitals Market by Geography (USD MN)
• Specialty Clinics Market by Geography (USD MN)
• Diagnostic Centers Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Preeclampsia Diagnostics Market by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Preeclampsia Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Preeclampsia Diagnostics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Test Type
• Market Attractiveness Analysis by Product Type
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Test Type (USD MN)
• Blood Tests Market by Geography (USD MN)
• Urine Analysis Market by Geography (USD MN)
• Global Market Analysis by Product Type (USD MN)
• Instruments Market by Geography (USD MN)
• Consumables Market by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospitals Market by Geography (USD MN)
• Specialty Clinics Market by Geography (USD MN)
• Diagnostic Centers Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC